These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1711939)

  • 1. The mechanism of action of cyclosporine: a perspective for the 90's.
    Halloran PF; Madrenas J
    Clin Biochem; 1991 Feb; 24(1):3-7. PubMed ID: 1711939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of immunosuppression by cyclosporins.
    Zenke G; Baumann G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH
    Ann N Y Acad Sci; 1993 Jun; 685():330-5. PubMed ID: 7689806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of FK 506 and cyclosporin.
    Steinmann B; Superti-Furga A; Bruckner P
    Lancet; 1991 Feb; 337(8738):439. PubMed ID: 1704088
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase.
    Kimball PM; Kerman RH; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine.
    Lane BC; Miller LN; Kawai M; Or YS; Wiedeman P; Holzman TF; Luly JR
    Transplant Proc; 1993 Feb; 25(1 Pt 1):644-6. PubMed ID: 7679829
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemistry and biology of the immunophilins and their immunosuppressive ligands.
    Schreiber SL
    Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the immunosuppressive properties of cyclosporine analogues.
    Reem GH; el Rouby S; Shi Y
    Ann N Y Acad Sci; 1993 Jun; 685():336-8. PubMed ID: 8363236
    [No Abstract]   [Full Text] [Related]  

  • 8. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?
    Sigal NH; Dumont F; Durette P; Siekierka JJ; Peterson L; Rich DH; Dunlap BE; Staruch MJ; Melino MR; Koprak SL
    J Exp Med; 1991 Mar; 173(3):619-28. PubMed ID: 1997649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activation.
    Ryffel B; Woerly G; Quesniaux VF; Husi H; Foxwell BM
    Biochem Pharmacol; 1992 Mar; 43(5):953-60. PubMed ID: 1554393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary DNA encoding the human T-cell FK506-binding protein, a peptidylprolyl cis-trans isomerase distinct from cyclophilin.
    Maki N; Sekiguchi F; Nishimaki J; Miwa K; Hayano T; Takahashi N; Suzuki M
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5440-3. PubMed ID: 1695378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
    Hess AD; Colombani PM
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
    [No Abstract]   [Full Text] [Related]  

  • 12. FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond.
    Siekierka JJ; Sigal NH
    Curr Opin Immunol; 1992 Oct; 4(5):548-52. PubMed ID: 1384551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine and its analogue SDZ IMM 125 mediate very similar effects on T-cell activation--a comparative analysis in vitro.
    Baumann G; Andersen E; Quesniaux V; Eberle MK
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):43-8. PubMed ID: 1496687
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
    Wasik M; Stepień-Sopniewska B; Lagodziński Z; Górski A
    Immunopharmacology; 1990; 20(1):57-61. PubMed ID: 1699911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression. Binding by design.
    Ringe D
    Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317
    [No Abstract]   [Full Text] [Related]  

  • 17. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.
    Flanagan WM; Corthésy B; Bram RJ; Crabtree GR
    Nature; 1991 Aug; 352(6338):803-7. PubMed ID: 1715516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of calcineurin by cyclosporin A-cyclophilin requires calcineurin B.
    Haddy A; Swanson SK; Born TL; Rusnak F
    FEBS Lett; 1992 Dec; 314(1):37-40. PubMed ID: 1333415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular targets of cyclosporine.
    Fairley JA
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1329-32; discussion 1332-4. PubMed ID: 2277142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.